UB Paderborn / Katalog / Suche / in CDI

Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis

Journal of personalized medicine, 2022-11, Vol.12 (11), p.1817

Bowirrat, Abdalla

2022

Link zum Volltext

Verfügbarkeit prüfen

Deep brain stimulation (DBS) may hold substantial promise for modulating memory and neural circuity in AD?

Journal of the neurological sciences, 2023-12, Vol.455, p.121374, Article 121374

Bowirrat, Abdalla

2023

Link zum Volltext

Verfügbarkeit prüfen

Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2005-01, Vol.132B (1), p.29-37

2005

Link zum Volltext

Verfügbarkeit prüfen

Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions

International journal of environmental research and public health, 2021-11, Vol.18 (21), p.11529

2021

Link zum Volltext

Verfügbarkeit prüfen

Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?

International journal of environmental research and public health, 2022-05, Vol.19 (11), p.6395

2022

Link zum Volltext

Verfügbarkeit prüfen

Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors

International journal of environmental research and public health, 2022-01, Vol.19 (1), p.552

2022

Link zum Volltext

Verfügbarkeit prüfen

Proposing a "Brain Health Checkup (BHC)" as a Global Potential "Standard of Care" to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of "Dopamine Homeostasis"

International journal of environmental research and public health, 2022-04, Vol.19 (9), p.5480

2022

Link zum Volltext

Verfügbarkeit prüfen

Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?

International journal of environmental research and public health, 2021-09, Vol.18 (18), p.9774

2021

Link zum Volltext

Verfügbarkeit prüfen

Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis

Frontiers in psychiatry, 2021-03, Vol.12, p.623403-623403

2021

Link zum Volltext

Verfügbarkeit prüfen

Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?

Journal of personalized medicine, 2022-02, Vol.12 (2), p.321

2022

Link zum Volltext

Verfügbarkeit prüfen

A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management"

Psychology research and behavior management, 2021-01, Vol.14, p.2115-2134

2021

Link zum Volltext

Verfügbarkeit prüfen

Neurogenetic and Epigenetic Aspects of Cannabinoids

Epigenomes, 2022-08, Vol.6 (3), p.27

2022

Link zum Volltext

Verfügbarkeit prüfen

Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy-A Case-Series

Journal of personalized medicine, 2023-02, Vol.13 (2), p.336

2023

Link zum Volltext

Verfügbarkeit prüfen

DNA Directed Pro-Dopamine Regulation Coupling Subluxation Repair, H-Wave® and Other Neurobiologically Based Modalities to Address Complexities of Chronic Pain in a Female Diagnosed with Reward Deficiency Syndrome (RDS): Emergence of Induction of “Dopamine Homeostasis” in the Face of the Opioid Crisis

Journal of personalized medicine, 2022-09, Vol.12 (9), p.1416

2022

Link zum Volltext

Verfügbarkeit prüfen

Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?

Journal of personalized medicine, 2022-10, Vol.12 (10), p.1719

2022

Link zum Volltext

Verfügbarkeit prüfen

A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration

Journal of personalized medicine, 2021-03, Vol.11 (3), p.212

2021

Link zum Volltext

Verfügbarkeit prüfen

Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature

Clinical Medicine Insights: Case Reports, 2014-01, Vol.2014 (2014), p.41-47

2014

Link zum Volltext

Verfügbarkeit prüfen

Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family

Journal of personalized medicine, 2022-11, Vol.12 (11), p.1864

2022

Link zum Volltext

Verfügbarkeit prüfen

Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects

Journal of personalized medicine, 2022-09, Vol.12 (9), p.1385

2022

Link zum Volltext

Verfügbarkeit prüfen

Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index

Journal of personalized medicine, 2022-10, Vol.12 (11), p.1772

2022

Link zum Volltext

Verfügbarkeit prüfen

Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing

Journal of personalized medicine, 2022-11, Vol.12 (12), p.1946

2022

Link zum Volltext

Verfügbarkeit prüfen

Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data

Journal of Alzheimer's disease, 2011-01, Vol.23 (2), p.349

2011

Link zum Volltext

Verfügbarkeit prüfen

Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation

Journal of personalized medicine, 2022-06, Vol.12 (6), p.1009

2022

Link zum Volltext

Verfügbarkeit prüfen

Neuro-Behçet's disease: a report of sixteen patients

Neuropsychiatric disease and treatment, 2010-01, Vol.6 (1), p.219-225

2010

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis

Deep brain stimulation (DBS) may hold substantial promise for modulating memory and neural circuity in AD?

Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome

Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions

Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?

Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors

Proposing a "Brain Health Checkup (BHC)" as a Global Potential "Standard of Care" to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of "Dopamine Homeostasis"

Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?

Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis

Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?

A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management"

Neurogenetic and Epigenetic Aspects of Cannabinoids

Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy-A Case-Series

Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?

A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration

Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature

Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family

Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects

Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index

Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing

Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data

Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation

Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids

Neuro-Behçet's disease: a report of sixteen patients

Suchergebnisse filtern